At-Home Drug of Abuse (DOA) Testing Market (Updated Version Available)

At-Home Drug of Abuse (DOA) Testing Market 2020 by Manufacturers, Growth, Size, Regions (Europe, Asia Pacific, North America and South America), Type, Trends and Application, Forecast to 2025

Report ID : RI_46398 | Date : April 2020 | Format : ms word ms Excel PPT PDF

This Report Includes The Most Up-To-Date Market Figures, Statistics & Data
The At-Home Drug of Abuse (DOA) Testing market had reached xxx million USD with a CAGR xx from 2015-2019. Later on, it will go to xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
The at-home DOA testing market has been categorized into rapid DOA test kits and breath analyzers.
The market is mainly driven by the increased production and trade of illicit drugs worldwide, growing use of illicit drugs amongst teenagers, and initiatives by government organizations to reduce the level of drug abuse.
In the global At-Home Drug of Abuse (DOA) Testing market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.

In global market, the following companies are covered:
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int\'l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products

Market Segment by Product Type:
Test Cups
Test Dip Cards
Test Strips
Others

Market Segment by Application:
Urine
Saliva
Hair
Others

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the At-Home Drug of Abuse (DOA) Testing market for the forecast period 2020 - 2025?
• What are the driving forces in the At-Home Drug of Abuse (DOA) Testing market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the At-Home Drug of Abuse (DOA) Testing industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
Select License
Single user : $3480   
Multi user : $5800   
Corporate user : $9000   
Buy Now

Secure SSL Encrypted

Immediate Delivery Available
Reports Insights
Why Choose Us
Guaranteed Success

Guaranteed Success

We gather and analyze industry information to generate reports enriched with market data and consumer research that leads you to success.

Gain Instant Access

Gain Instant Access

Without further ado, choose us and get instant access to crucial information to help you make the right decisions.

Best Estimation

Best Estimation

We provide accurate research data with comparatively best prices in the market.

Discover Opportunitiess

Discover Opportunities

With our solutions, you can discover the opportunities and challenges that will come your way in your market domain.

Best Service Assured

Best Service Assured

Buy reports from our executives that best suits your need and helps you stay ahead of the competition.

Customer Testimonials

Reports Insights have understood our exact need and Delivered a solution for our requirements. Our experience with them has been fantastic.

MITSUI KINZOKU, Project Manager

I am completely satisfied with the information given in the report. Report Insights is a value driven company just like us.

Privacy requested, Managing Director

Report of Reports Insight has given us the ability to compete with our competitors, every dollar we spend with Reports Insights is worth every penny Reports Insights have given us a robust solution.

Privacy requested, Development Manager

Select License
Single user : $3480   
Multi user : $5800   
Corporate user : $9000   
Buy Now

Secure SSL Encrypted

Reports Insights
abbott Mitsubishi Corporation Pilot Chemical Company Sunstar Global H Sulphur Louis Vuitton Brother Industries Airboss Defence Group UBS Securities Panasonic Corporation